Medicine delivery startup Gmedes secures funding in 500 Startups-led round

Singapore-based healthtech startup Gmedes has raised an undisclosed amount of pre-series A funding in a round led by 500 Startups’ Southeast Asia funds, 500 Durians and 500 Tuk Tuks.

Photo credit: Treasure

Claiming to be the world’s first global e-pharmacy delivery service, Gmedes has developed the G-Meds app to enable doctors, clinics, and hospitals to prescribe, bill, and deliver medicines to their patients. The app takes care of both the front-end and back-end compliant processes, including delivery, customs clearing, logistics tracking, and import taxes.

It plans to use the new funds to establish partnerships to implement the G-Meds service for medical institutions across Singapore, Indonesia, China, Malaysia, the Philippines, and Indochina.

Gmedes CEO Dennis Susay said there is a significant opportunity for a global medicine delivery service, especially with patients traveling from China, Central Asia, Indochina, and India. “This is especially important for Southeast Asia, which is a significant global medical tourism hub, with an estimated annual 5 million traveling patients,” he added.

In addition to foreign patients, the company also launched a local prescription delivery service in response to demand from doctors, clinics, and caregivers. Gmedes also looks to launch a specialty therapies sourcing and delivery solution soon, aiming at hospitals seeking specialized medications not readily available in their markets.

Through its partnerships, Gmedes has available medication on its platform for key chronic and specialty therapeutic areas such as cardiology, respiratory, arthritis and rheumatoid arthritis, dermatology, and mental health.

In addition to medicines, G-Meds also provides nutritional supplements, medical disposals, infant formulas, and clinical aesthetics. It is available for users residing in Southeast Asia, China, Japan, the Middle East, the UK, and North America.